
PPCB P/E Ratio
P/E Ratio as of Sep 8, 2025: -0.02
Average-0.0330
Median-0.0250
Minimum-0.0800
Maximum-0.0200
-0.02
Past Month+0.03 (60.00%)
The P/E ratio for PPCB is -0.02 as of Sep 8, 2025. This represents a decrease of -99.91% compared to its 12-month average P/E ratio of -22.91. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Propanc Biopharma Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Propanc Biopharma Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Propanc Biopharma Inc to industry peers.
Propanc Biopharma Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Propanc Biopharma Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Propanc Biopharma Inc to industry peers.
PPCB P/E Ratio Insights
See Propanc Biopharma Inc’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in PPCB
Order type
Buy in
Order amount
Est. shares
0 shares
PPCB P/E Ratio Historic Data
Date | Stock price | P/E ratio |
---|---|---|
Sep 2, 2025 | $2.73 | -0.02 |
Aug 1, 2025 | $9.60 | -0.08 |
Jul 1, 2025 | $4.15 | -0.03 |
Jun 2, 2025 | $2.50 | -0.02 |
May 1, 2025 | $4.00 | -0.01 |
Apr 1, 2025 | $5.50 | -0.01 |
Mar 3, 2025 | $6.00 | -0.01 |
Feb 3, 2025 | $10.00 | -274.73 |
Jan 2, 2025 | $24.00 | -0.04 |
PPCB End of Year P/E Ratio
Date | P/E ratio | Change |
---|---|---|
2025 | -0.02 | 0.00% |
2024 | -0.02 | +100.00% |
2023 | -0.01 | -50.00% |
2022 | -0.02 | -88.89% |
2021 | -0.18 | 0.00% |
2020 | 0.00 | — |
FAQs About Propanc Biopharma Inc (PPCB) P/E ratio
The latest P/E ratio of PPCB is -0.02, as of Sep 8, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Propanc Biopharma Inc’s last 12-month average P/E ratio is -22.91, compared to its current P/E ratio of -0.02. This reflects a decrease of -99.91%.
Propanc Biopharma Inc’s current P/E ratio of -0.02 is lower than its last 12-month average P/E of -22.91. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Propanc Biopharma Inc’s average P/E ratio over the last 3 years is -7.65. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Propanc Biopharma Inc’s average P/E ratio over the last 5 years is -4.6. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.